Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
US FDA approves new nasal spray for depression treatment
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.
FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment
Spravato is now the first-ever standalone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had
Psychology Today
4d
New Strategies for Treatment-Resistant Depression
Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...
Inquirer on MSN
1d
Ketamine a lifeline for severe depression patients in Singapore
Ketamine, the controlled drug best known as a horse tranquilizer or party supplement, has in the last four years become a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
Legendary guitarist dies
Prince Harry settles suit
Soda button reinstalled
Launches bid for governor
Turns down plea deal
2,000-year-old statue found
Murder charge upheld
Faces new allegations
SCOTUS grants new hearing
DEI staff placed on leave
Files $500M defamation suit
1st Japanese elected to HOF
Silk Road founder pardoned
Raising prices again
The Band's keyboardist dies
Meta ex-COO sanctioned
Can target schools, churches
Bryan pastor found guilty
Refugee arrivals suspended
Wildfires near San Diego
FDA approves nasal spray
Houthi rebels release crew
Voice of Navy football dies
Antisemitism lawsuits settled
Record-breaking snow
Doug Collins hearing
'Days of Our Lives' star dies
Trailblazing cartoonist dies
Coast Guard chief fired
Related topics
Johnson & Johnson
Food and Drug Administration
Spravato
ketamine
Feedback